Horizon Pharma plc to Participate in Three Investor Conferences in February

DUBLIN, IRELAND--(Marketwired - Jan 28, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate at the following conferences in February:

Canaccord Genuity 2016 Rare Disease, BioPharma 1x1 Day

• Date: February 2, 2016
• Location: New York, NY

BIO CEO & Investor Conference

• Presentation Date: February 8, 2016
• Presentation Time: 2:30 p.m. ET
• Location: New York, NY

LEERINK Partners 5th Annual Global Healthcare Conference

• Date: February 10, 2016
• Presentation Time: 9:15 a.m. ET
• Location: New York, NY

For the above conferences with presentations, they will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcasts will be available for the events with presentations.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, primary care and rheumatology business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:
John Thomas
Executive Vice President, Strategy and Investor Relations
[e-mail]

Tina Ventura
Vice President, Investor Relations
[e-mail]

U.S. Media:
Geoff Curtis
Senior Vice President, Corporate Communications
[e-mail]

Ireland Media:
Ray Gordon
Gordon MRM
[e-mail]